From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area

Jordan E Axelrad, Lisa Malter, Simon Hong, Shannon Chang, Brian Bosworth, David Hudesman
2020 Inflammatory Bowel Diseases  
Background We aimed to characterize patients with inflammatory bowel disease (IBD) and novel coronavirus disease 2019 (COVID-19). Methods We performed a case series of patients with IBD and confirmed or highly suspected COVID-19 to assess rates of severe outcomes. Results We identified 83 patients with IBD with confirmed (54%) or highly suspected (46%) COVID-19. The overall hospitalization rate was 6%, generally comprising patients with active Crohn's disease or older men with comorbidities,
more » ... h comorbidities, and 1 patient expired. Discussion In this series of patients with IBD, severe outcomes of COVID-19 were rare and comparable to similarly aged individuals in the general population.
doi:10.1093/ibd/izaa162 pmid:32578843 fatcat:k2mzabxwlbbxtkwn3aaq6dri4a